Cerus Corporation (CERS)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Blood Safety	180.27M	156.37M	162.05M	130.86M	91.92M
Blood Safety Growth	15.29%	-3.51%	23.83%	42.36%	23.14%
Total	180.27M	156.37M	162.05M	130.86M	91.92M
Total Growth	15.29%	-3.51%	23.83%	42.36%	23.14%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Other Countries	49.51M	44.65M	41.33M	42.47M	41.00M
Other Countries Growth	10.89%	8.02%	-2.69%	3.60%	20.72%
United States	111.07M	93.23M	101.39M	67.50M	31.52M
United States Growth	19.14%	-8.05%	50.21%	114.16%	52.91%
France	19.69M	18.49M	19.33M	20.89M	19.40M
France Growth	6.50%	-4.33%	-7.47%	7.64%	-3.34%
Total	180.27M	156.37M	162.05M	130.86M	91.92M
Total Growth	15.29%	-3.51%	23.83%	42.36%	23.14%

Source: S&P Global Market Intelligence.